Research Institute Scale and Structure

The SCBM Biopharmaceutical Innovation Research Institute spans approximately 4,300 square meters. Under the leadership of Director Ye Hejia, it comprises eight core technology platforms

- Influenza Technology Platform  

- Genetic Engineering Technology Platform  

- Cell Process Technology Platform  

- Fermentation Process Technology Platform  

- Process Innovation Technology Platform  

- Diagnostic Center Technology Platform  

- Laboratory Animal Registration Platform  

- Product Registration Platform  

These platforms comprehensively cover the entire R&D process for poultry, pet, and aquatic vaccines.

Specialized Laboratory Facilities

The institute is equipped with fully functional specialized laboratories, including:  

- Clean Cell Culture Room  

- Suspension Cell Engineering Laboratory  

- Reverse Genetics Laboratory  

- Genetic Engineering Laboratory  

- Exogenous Virus Detection Room  

- Microbiology Laboratory  

- Fermentation Engineering Laboratory  

- Emulsification Process Laboratory  

- Molecular Biology Laboratory  

These facilities fully meet the requirements for project development and pilot-scale testing.

Advanced Equipment Investment

- Automated Nucleic Acid Extraction Systems  

- Fluorescent Quantitative PCR Instruments  

- High-Speed Refrigerated Centrifuges  

- Vacuum Freeze Dryers  

- High-Shear Dispersion Homogenizers  

- Fluorescence Microscopes  

- Microplate Readers  

- Purification Equipment  

- Ultra-Low Temperature Incubators  

- Viscometers  

- CO? Incubators  

Technological Advantages

The well-equipped laboratories and advanced instruments provide robust support for all R&D projects.

Through systematic platform development, specialized laboratory spaces, and cutting-edge equipment, the institute has established a comprehensive technology system covering the entire vaccine R&D process, ensuring efficient progress in technological innovation and product development.